Osteoking promotes bone formation and bone defect repair through ZBP1-STAT1-PKR-MLKL-mediated necroptosis
Abstract Background Osteoking has been used for fracture therapy with a satisfying clinical efficacy. However, its therapeutic properties and the underlying mechanisms remain elusive. Method A bone defect rat model was established to evaluate the pharmacological effects of Osteoking by the dynamic o...
Saved in:
Main Authors: | Suya Zhang (Author), Yudong Liu (Author), Zhaochen Ma (Author), Shuangrong Gao (Author), Lin Chen (Author), Honggang Zhong (Author), Chu Zhang (Author), Tao Li (Author), Weiheng Chen (Author), Yanqiong Zhang (Author), Na Lin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis
by: Yaxian Liu, et al.
Published: (2022) -
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
by: Qin Dai, et al.
Published: (2020) -
Clinical efficacy of Osteoking in knee osteoarthritis therapy: a prospective, multicenter, non-randomized controlled study in China
by: Jun Zhou, et al.
Published: (2024) -
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
by: Fu-li Shi, et al.
Published: (2023) -
Effect of Osteoking on the osteogenic and adipogenic differentiation potential of rat bone marrow mesenchymal stem cells in vitro
by: Congtao Yu, et al.
Published: (2019)